cardiovascular disease, such as obesity, insulin resistance, hypertension, and hyperlipidemia. Moreover, the hypoxia, negative intrathoracic pressure, and arousal induced by upper-airway obstruction during sleep, as well as repeated activation of the sympathetic nervous system, have various effects on blood pressure and coagulation factors that may lead to an increased risk of cardiovascular morbidity. [7] [8] [9] [10] Recent studies have investigated the effect of OSA on atherosclerosis, and it has been demonstrated that the levels of soluble adhesion molecules, vascular endothelial growth factor (VEGF), and coagulation factors are increased in OSA patients, compared with control subjects, and are significantly decreased by the use of nasal continuous positive airway pressure (NCPAP) therapy. [11] [12] [13] [14] [15] These studies have suggested that OSA may be associated with the progression of atherosclerosis but did not assess atherosclerosis itself.
INTRODUCTION

OBSTRUCTIVE SLEEP APNEA (OSA) HAS BEEN SUGGESTED TO BE ONE OF THE RISK FACTORS FOR STROKE, CARDIOVAS-CULAR DISEASE, AND EARLY MORTALITY.
Patients with OSA frequently have multiple risk factors for cardiovascular disease, such as obesity, insulin resistance, hypertension, and hyperlipidemia. Moreover, the hypoxia, negative intrathoracic pressure, and arousal induced by upper-airway obstruction during sleep, as well as repeated activation of the sympathetic nervous system, have various effects on blood pressure and coagulation factors that may lead to an increased risk of cardiovascular morbidity. [7] [8] [9] [10] Recent studies have investigated the effect of OSA on atherosclerosis, and it has been demonstrated that the levels of soluble adhesion molecules, vascular endothelial growth factor (VEGF), and coagulation factors are increased in OSA patients, compared with control subjects, and are significantly decreased by the use of nasal continuous positive airway pressure (NCPAP) therapy. [11] [12] [13] [14] [15] These studies have suggested that OSA may be associated with the progression of atherosclerosis but did not assess atherosclerosis itself.
As a method of evaluating atherosclerosis, the carotid-artery intimamedia thickness (IMT) can be measured by ultrasonography. It has been reported that the carotid-artery IMT measured by ultrasonography is strongly correlated with the IMT measured by pathologic examination 16 and that an increase of IMT is associated with an increased risk of stroke and cardiovascular disease. [17] [18] [19] [20] [21] [22] [23] [24] Accordingly, ultrasonographic IMT measurement has recently become established as a method of assessing the early stage of atherosclerosis. It also has been reported that the carotid-artery IMT is increased in patients with hypertension, hyperlipidemia, or diabetes mellitus, as well as in the elderly. [25] [26] [27] [28] [29] We hypothesized that the carotid-artery IMT might be increased in OSA patients as a result of the effects of sleep apnea that promote atherosclerosis. To test this hypothesis, we measured the carotid-artery IMT by ultrasonography to evaluate atherosclerosis in simple snorers and patients with OSA. Silvestrini and colleagues recently reported that the carotid-artery IMT is significantly greater in patients with severe OSA than in control subjects. 30 In the present study, we aimed to confirm their findings as well as to elucidate the relationship between the severity of OSA and the carotid-artery IMT.
METHODS
Subjects
Among 215 patients who attended our hospital with symptoms of OSA or for diagnostic polysomnography (PSG) from January 2000 to August 2001, 195 who consented to enter this study were enrolled. A questionnaire was used to obtain data on their medical history, current medications, and smoking history. We explained the purpose of this study and the procedures to the subjects and obtained written consent from all of them. The protocol of this study was approved by the institutional review board. We excluded patients who had a history of chronic obstructive pulmonary disease, cerebrovascular disease, or cardiovascular disease. We also excluded patients younger than 20 years of age. As a result, 167 patients were available for investigation. All 167 subjects were Japanese. None of them received NCPAP therapy before or during the study.
Anthropometric Measurements
Body weight and height were measured before the PSG, and the body mass index (BMI) was calculated as weight (kilograms) divided by the square of height (meters). In the morning after PSG, blood pressure was measured using an automated sphygmomanometer after the patient had rested for at least 5 minutes in the supine position. Hypertension was defined as a diastolic pressure greater than 90 mm Hg, a systolic pressure greater than 140 mm Hg, or use of antihypertensive medication.
Sleep Studies
Overnight PSG was performed on all subjects. Data acquisition started at 9:00 PM and continued until 6:00 AM the next morning. Nasal airflow was monitored by a thermistor (Nihon Kohden, Tokyo, Japan), arterial hemoglobin oxygen saturation was measured with a pulse oximeter (Pulsox 7, Minolta, Tokyo, Japan), and thoracoabdominal wall motion was recorded by respiratory inductance plethysmography ([RIP] Respitrace, Ambulatory Monitoring Inc., NY, USA). Sleep patterns were monitored from the electroencephalogram (C3/A2), electrooculogram, and submental electromyogram using the international 10-20 system of electrode placement for electroencephalography. An apnea was defined as cessation of airflow for at least 10 seconds, and a hypopnea was defined as a decrease in RIP sum by at least 50% for a minimum of 10 seconds or a clear decrease in RIP sum (> 20%) followed by either oxygen desaturation of 3% or more or signs of physiologic arousal. 31 From these data, the apnea-hypopnea index (AHI) was calculated as the number of apnea and hypopnea events per hour of total sleeping time. To assess the severity of hypoxemia induced by OSA, we also measured the duration of oxygen saturation below 90%, which was expressed as a percentage of the total sleeping time (T90), and the mean nadir oxygen saturation related to apneahypopnea events.
Blood Collection
When the subjects awakened after the PSG (6:00 AM), blood samples were collected to screen for diabetes mellitus and hyperlipidemia. The plasma levels of total cholesterol, h i g h -d e n s i t y lipoprotein cholesterol, triglycerides, glucose, glycosylated hemoglobin (HbA 1c ), and immunoreactive insulin (IRI) were measured by the hospital laboratory according to routine procedures. An oral glucose tolerance test was also performed. Insulin resistance was estimated by calculation of ΣIRI and by the homeostasis model assessment method . The ΣIRI was calculated as the sum of the IRI values at 0 minutes, 30 minutes, and 120 minutes. The homeostasis model assessment method was calculated by the following formula: IRI (µU/mL) × fasting glucose (mg/dL) / 405.
Hyperlipidemia was defined as a total cholesterol greater than 240 mg/dL or use of lipid-lowering medication. Diabetes mellitus was defined as a fasting glucose greater than 140 mg/dL, a glucose level greater than 200 mg/dL at 120 minutes in the oral glucose tolerance test, or use of antidiabetic medication.
Measurement of Carotid-artery IMT
Ultrasonography of the carotid arteries was performed before PSG to ensure that the investigators were unaware of the PSG results. Measurements were obtained with a B-mode high-resolution ultrasound apparatus using an 11.0-MHz probe (Powervision 6000, Toshiba Medical, Tokyo, Japan) on a real-time basis. Scanning of the extracranial carotid arteries in the neck was done bilaterally in 3 different (anterior, lateral, and posterior-oblique) longitudinal projections and in the transverse projection. This allowed visualization of the common carotid artery, carotid bulb, and parts of the internal and external carotid arteries. The image of the vessel was projected on a monitor, and the ultrasound beam was adjusted until it was perpendicular to the surface of the far wall of the vessel in order to obtain 2 parallel echogenic lines. The first line represented the lumen-intima interface and the second line was produced by the collagen-containing upper layer of adventitia close to the media-adventitia transition, so the IMT was measured as the distance from the lumen-intima interface to the media-adventitia transition 17, 32 ( Figure 1) . In each longitudinal projection, the IMT was measured at the site of greatest thickness, as well as 1 cm upstream and 1 cm down- 
Plaque was defined as a localized thickening greater than 1.1 mm, and sites with plaque were not used for IMT measurement. Some previous investigations using the same methods as the present study have shown that the carotid-artery IMT did not exceed 1.1 mm, and there was no plaque in the healthy control group at any age. 33, 34 Therefore, atherosclerosis was defined as an IMT greater than 1.1 mm, the presence of plaque, or both.
Statistical Analysis
Analyses were performed using the SPSS2 for Windows package (SPSS, Inc., Chicago, Ill). Relationships between the IMT and other variables were investigated by Pearson's correlation analysis. Multiple regression analysis was employed to identify variables that were independently associated with the IMT and to adjust for confounding factors. Because of the skewed distribution of data and to prevent an undue influence of outlying observations, log transformation of the data was performed (natural log [x + 0.1]).
A probability value of less than .05 was regarded as indicating statistical significance, and results were expressed as the mean ± SD.
RESULTS
Patient Characteristics
The subjects had a mean age of 47.2 ± 13.0 years, a mean BMI of 27.4 ± 4.7 kg/m 2 , and a mean AHI of 36.0 ± 27.1. The risk factors of the subjects were as follows: 29.3% were smokers, 47.3% had hypertension, 18.0% had hyperlipidemia, and 17.4% had diabetes mellitus (Table 1) .
Correlations Between IMT and the Variables of Sleep-Disordered Breathing
The IMT was significantly correlated with the AHI (r = 0.327; P < .001), T90 (r = 0.354; P < .001), and the mean nadir oxygen saturation (r = -0.331; P < .001) by Pearson's correlation analysis. Figure 2 shows scatterplots of the IMT versus the AHI, T90, and the mean nadir oxygen saturation. The IMT was also significantly correlated with age (r = 0.469; P < .001), BMI (r = 0.188; P < .05), total cholesterol (r = 0.187; P < .05), HbA 1c (r = 0.264; P < .001), and systolic blood pressure (r = 0.174; P < .05) by the same analysis.
Multiple Regression Analysis
Previous studies have shown that the following factors are associated with the progression of IMT: age, obesity, sex, smoking, hypertension, diabetes, and hyperlipidemia. [25] [26] [27] [28] [29] Other than the factors associated with sleep-disordered breathing, the present study indicated that the following factors were correlated with IMT: age, BMI, total cholesterol, HbA 1c , and systolic blood pressure. Therefore, the following were selected as confounding factors associated with the progression of IMT: age, BMI, sex, total cholesterol, HBA 1c , systolic blood pressure, and smoking history. Furthermore, since it has been reported that the use of medication for the treatment of hypertension, diabetes, and hyperlipidemia can reduce the IMT, 27, 35, 36 the use of such drugs was also included as a confounding factor. The patient's sex, smoking history, and use of each class of drugs were included as dummy variables. Then multiple regression analysis was performed to assess the association between IMT and the parameter on sleep-disordered breathing, adjusting for these confounding factors. It was found that AHI, T90, and mean nadir oxygen saturation were significantly associated with IMT even after adjustment for the confounding factors (Table 2) . Next, multiple regression analysis was performed to assess the influence of the severity of hypoxemia and the frequency of obstructive events on the IMT. We constructed 2 models that included AHI and 1 of the 2 measures of OSA-related hypoxemia, as well as other confounding factors as the independent variables. This analysis showed that the AHI was not significantly associated with the IMT (standard regression coefficient: β = 0.114, P = .1134), but T90 was significantly associated with it (β = 0.221, P = .0118) and so was the mean nadir oxygen saturation (AHI: β = 0.111, P = .1804, mean nadir oxygen saturation: β = -0.202, P = .0152). These results indicate that OSA-related hypoxemia is significantly associated with the IMT independently of the AHI.
OSA and Carotid-Artery Intima-Media IMT refers to intima-media thickness; AHI, apnea-hypopnea index, which is the number of apneas and hypopneas per hour of sleep; BMI, body mass index, which is the weight in kilograms divided by the height in meters squared; T-cho, total cholesterol; HbA 1c , glycosylated hemoglobin; SBP, systolic blood pressure; T90, the duration of an oxygen saturation below 90%, which is expressed as a percentage of the total sleeping time. 
DISCUSSION
The present study demonstrated that the carotid-artery IMT, an index of systemic atherosclerosis, was significantly correlated with the severity of OSA (AHI, T90, and mean nadir oxygen saturation). We investigated the influence of other factors related to the progression of atherosclerosis, including hypertension, diabetes, hyperlipidemia, obesity, aging, and use of medications. [25] [26] [27] [28] [29] 35, 36 Even after adjustment for these potential confounding factors, however, the IMT was still significantly associated with the severity of OSA. Among the parameters that we used to assess the severity of OSA, hypoxemia (T90 and mean nadir oxygen saturation) seemed to be more important than the frequency of obstructive events because it was independently associated with the IMT and the AHI was not. Therefore, our findings suggest that OSA-related hypoxemia is an independent contributor to the severity of carotid-artery atherosclerosis.
Many previous investigations have shown that cerebrovascular or cardiovascular events increase along with an increase of the IMT, as measured by ultrasonography. [17] [18] [19] [20] [21] [22] [23] [24] Also, it has been reported that the maximal IMT is more closely related to the risk of myocardial infarction and stroke than is the mean IMT. 19, 23 Based on these reports, we used the maximum IMT value for analysis in the present study.
Recently, a relationship between OSA and hypertension has been established by cross-sectional population studies, as well as by a prospective study. [37] [38] [39] Hypertension itself is a strong promoter of atherosclerosis, and our results also showed that systolic blood pressure was correlated with the IMT. Therefore, high blood pressure seems to contribute to an increase of the IMT. However, there was a relationship between OSA and the carotid-artery IMT even after adjustment for blood pressure, raising the possibility that OSA can also promote atherosclerosis through mechanisms other than an increase of blood pressure. Recent studies have shown that VEGF may contribute to the process of atherogenesis. It has been reported that hypoxia is a major stimulus that increases the concentration of VEGF, which induces the activation and migration of monocytes, modulates the growth of smooth muscle cells, and is closely related to the progression of coronary-artery atherosclerosis and the extent of carotid-artery stenosis. [40] [41] [42] [43] [44] It has also been reported that VEGF levels are increased in OSA patients, compared with control subjects, and are significantly decreased by NCPAP therapy. 14, 15 These findings could help to explain how OSA-related hypoxemia may contribute to the progression of atherosclerosis.
Our study had several limitations. First, all of the subjects were referred with symptoms of OSA. They may have had more risk factors for atherosclerosis than do asymptomatic subjects, so we cannot exclude the possibility that our population sample was biased. Second, although the IMT was measured before performance of PSG to blind the investigators to data on sleep-disordered breathing, it was impossible to completely exclude a potential bias based on the physical attributes of the subjects, such as obesity, because IMT was measured on a real-time basis. However, this potential bias did not directly lead to high IMT values in our OSA patients because the severity of OSA was associated with the IMT independently of BMI (a factor closely related to the body habitus). Third, our method of IMT measurement was not examined for reproducibility, but it seems more likely that observer variability would have weakened rather than strengthened the relationship between IMT and OSA. Finally, this was a cross-sectional study, so we could not assess the causal relationship between IMT and OSA. To clarify this point, a prospective study involving clinical intervention will be needed.
Previous studies have evaluated the relationship between OSA and the causal factors or consequences of atherosclerosis but have not assessed the actual severity of atherosclerosis itself. In contrast, we evaluated the severity of carotid-artery atherosclerosis based on the IMT and demonstrated a correlation between the severity of atherosclerosis and that of OSA. Moreover, we found that the IMT was independently associated with OSA-related hypoxemia but not with the AHI. To the best of our knowledge, this is the first demonstration of an independent association between hypoxemia related to OSA and the severity of atherosclerosis.
In conclusion, our findings demonstrated that OSA is independently related to atherosclerosis, and that the severity of OSA-related hypoxemia is more important than is the frequency of obstructive events.
